|
1
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J and
Thun MJ: Cancer statistics, 2009. CA Cancer J Clin. 59:225–249.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bokhman JV: Two pathogenetic types of
endometrial carcinoma. Gynecol Oncol. 15:10–17. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Clemmons DR: Modifying IGF1 activity: An
approach to treat endocrine disorders atherosclerosis and cancer.
Nat Rev Drug Discov. 6:821–833. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yu H and Rohan T: Role of the insulin-like
growth factor family in cancer development and progression. J Natl
Cancer Inst. 92:1472–1489. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bruchim I, Sarfstein R and Werner H: The
IGF hormonal network in endometrial cancer: Functions, regulation
and targeting approaches. Front Endocrinol (Lausanne).
5:762014.
|
|
6
|
Walker MP, Diaugustine RP, Zeringue E, et
al: An IGF1/insulin receptor substrate-1 pathway stimulate a
mitotic kinase (cdk1) in the uterine epithelium during the
proliferative response to estradiol. J Endocrinol. 207:225–235.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Enders GH and Maude SL: Traffic safety for
the cell: Influence of cyclic-dependent kinase activity on genomic
stability. Gene. 371:1–6. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tang H, Liao Y, Xu L, Zhang C, Liu Z, Deng
Y, Jiang Z, Fu S, Chen Z and Zhou S: Estrogen and insulin-like
growth factor 1 synergistically promote the development of lung
adenocarcinoma in mice. Int J Cancer. 133:2473–2482. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rotwein P, Pollock KM, Didier DK and Krivi
GG: Organization and sequence of the human insulin-like growth
factor I gene. Alternative RNA processing produces two insulin-like
growth factor I precursor peptides. J Biol Chem. 261:4828–4832.
1986.PubMed/NCBI
|
|
10
|
Adamo ML, Neuenschwander S, LeRoith D and
Roberts CT Jr: Structure, expression and regulation of the IGF-I
gene. Adv Exp Med Biol. 343:1–11. 1993. View Article : Google Scholar
|
|
11
|
Yu H, Li BD, Smith M, Shi R, Berkel HJ and
Kato I: Polymorphic CA repeats in the IGF-I-gene and breast cancer.
Breast Cancer Res Treat. 70:117–122. 2001. View Article : Google Scholar
|
|
12
|
Coletta RR, Jorge AA, D'Alva CB, Pinto EM,
Billerbeck AE, Pachi PR, Longui CA, Garcia RM, Boguszewski M,
Arnhold IJ, et al: Insulin-like growth factor 1 gene (CA)n repeats
and a variable number of tandem repeats of the insulin gene in
Brazilian children born small for gestational age. Clinics
(SaoPaulo). 68:785–791. 2013. View Article : Google Scholar
|
|
13
|
Bläker H, Warth A, Kloor M and Schirmacher
P: Chromosomal instability, microsatellite instability and CpG
island methylator phenotype: Roles in small intestinal
carcinogenesis. Pathologe. 32(Suppl 2): 181–184. 2011. View Article : Google Scholar
|
|
14
|
Avruch J: MAP kinase pathway: The first
twenty years. Biochim Biophys Acta. 1773:1150–1160. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rutanen EM: Insulin-like growth factors
and insulin-like growth factor binding proteins in the endometrium.
Effect of intrauterine levonorgestrel delivery. Hum Reprod.
15(Suppl 3): 173–181. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Creasman W: Revised FIGO staging for
carcinoma of the endometrium. Int J Gynaecol Obstet. 105:1092009.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kaczmarek M, Pacholska-Bogalska J,
Kwaśniewski W, Kotarski J, Halerz-Nowakowska B and
Goździka-Józefiak A: A microsatellite polymorphism in IGF1 gene
promoter and timing of natural menopause in Caucasian women. Int J
Med Sci. 12:32–41. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bruchim I and Werner H: Targeting IGF-1
signaling pathways in gynecological malignancies. Expert Opin Ther
Targets. 17:307–320. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Werner HM and Salvesen HB: Current status
of molecular biomarkers in endometrial cancer. Curr Oncol Rep.
16:403–414. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bruchim I, Sarfestein R and Werner H: The
IGF hormonal network in endometrial cancer: Functions, regulation
and targeting approaches. Front Endocrinol (Lausanne).
5:762014.
|
|
21
|
Pollak M: Insulin-like growth factor
signaling in neoplasia. Nat Rev Cancer. 8:915–928. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gunter MJ, Hoover DR, Herbert Yu,
Wassertheil-Smoller S, Manson JE, Li J, Harris TG, Rohan TE, Xue X,
Ho GY, et al: A prospective evaluation of insulin and insulin-like
growth factor-I as risk factors for endometrial cancer. Cancer
Epidemiol Biomarkers Prev. 17:921–929. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ayabe I, Tsutsumi O, Sakai A, Yoshikawa H,
Yano T, Kurimoto F and Taketani Y: Increased circulating levels of
insulin-like growth factor-I and decreased circulating levels of
insulin-like growth factor binding protein-1 in postmenoausal women
endometrial cancer. Endocr J. 44:419–424. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Petridou E, Koukoulomatis P, Alexe DM,
Voulgaris Z, Spanos E and Trichopoulos D: Endometrial cancer and
the IGF system: A case-control study in Greece. Oncology.
64:341–345. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cao Y, Nimptsch K, Shui IM, Platz EA, Wu
K, Pollak MN, Kenfield SA, Stampfer MJ and Giovannucci EL:
Prediagnostic plasma IGFBP-1, IGF-1 and risk of prostate cancer.
Inter J Cancer. 10:2418–2426. 2015. View Article : Google Scholar
|
|
26
|
Ma J, Sawai H, Matsuo Y, Ochi N, Yasuda A,
Takahashi H, Wakasugi T, Funahashi H, Sato M and Takeyama H: IGF-1
mediates PTEN suppression and enhances cell invasion and
proliferation via activation of the IGF-1/PI3K/Akt signaling
pathway in pancreatic cancer cells. J Surg Res. 160:90–101. 2010.
View Article : Google Scholar
|
|
27
|
Cleveland RI, Gammon MD, Edmiston SN,
Teitelbaum SL, Britton JA, Terry MB, Eng SM, Neugut AI, Santella RM
and Conway K: IGF1 CA repeat polymorphisms, lifestyle factors and
breast cancer risk in the long island breast cancer study project.
Carcinogenesis. 27:758–765. 2006. View Article : Google Scholar
|
|
28
|
Rietveld I, Janssen J, Hofman A, Pols HA,
van Duijn CM and Lamberts SW: A polymorphism in the IGF-1 gene
influence the age-related decline in circulating total IGF-1
levels. Eur J Endocrinol. 148:171–175. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jernström H, Chu W, Vesprini D, et al:
Genetic factors related to racial variation in plasma levels of
insulin-like growth factor 1: Implications for premenopausal breast
cancer risk. Mol Genet Metab. 72:144–154. 2001. View Article : Google Scholar
|
|
30
|
Chrostopoulos PF, Msaouel P and
Koutsilieris M: The role of the insulin-like growth factor-1 system
in breast cancer. Mol Cancer. 14:432015. View Article : Google Scholar
|
|
31
|
Javadi M, Hematti S and Tavassoli M:
Polymorphic CA repeat length in insulin-like growth factor 1 and
risk of breast cancer in Iranian women. Med Oncol. 29:516–520.
2012. View Article : Google Scholar
|
|
32
|
Zecevic M, Amos CHI, Gu X, Campos IM,
Jones JS, Lynch PM, Rodriguez-Bigas MA and Frazier ML: IGF1 gene
polymorphism and risk for hereditary nonpolyposis colorectal
cancer. J Natl Cancer Inst. 98:139–143. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liang YJ, Hao Q, Zhang HM, Wu YZ and Wang
JD: Insulin like growth factors in endometroid adenocarcinomas:
Correlation with clinic-pathological features and estrogen receptor
expression. BMC Cancer. 12:262–274. 2012. View Article : Google Scholar
|
|
34
|
Billard J, Grewal SS, Lukaeskol P, Stork
PJ and Rotwein P: Hormonal control of insulin like growth factor 1
gene transcription in human osteoblasts: Dual actions of cAMP
dependent protein kinase on CCAAT/enhancer-binding protein delta. J
Biol Chem. 276:31238–31246. 2001. View Article : Google Scholar
|
|
35
|
Bender D, Buekers T and Leslie KK:
Hormones and receptors in endometrial cancer. Proc Obstet Gyn.
2:1–25. 2011.
|
|
36
|
Groothuis PG, Dassen HH, Romano A and
Punyadeera C: Estrogen and the endometrium: Lessons learned from
gene expression profiling in rodents and human. Hum Reprod Update.
13:405–417. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Denduluri SK, Idowu O, Wang Z, Liao Z, Yan
Z, Mohammed MK, Ye J, Wei Q, Wang J, Zhao L and Luu HH:
Insulin-like growth factor (IGF) signaling in tumorigenesis and the
development of cancer drug resistance. Genes Dis. 2:13–25. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Broniarczyk J, Kedzia A, Nowak W,
Koscinski ł, Lewandowski M and Gozdzicka-Jozefiak A: Polymorphisms
in the P1 promoter of the IGF-1 gene in children with growth
disorders. Pediatr Endocrinol Diabetes Metab. 20:136–142. 2015.
View Article : Google Scholar : PubMed/NCBI
|
